From Portugal to the World: building a new future for the family medicine
DOI:
https://doi.org/10.32385/rpmgf.v37i6.13406Keywords:
APMGF, WONCAAbstract
O ano de 2021, como já tinha acontecido em 2020, foi vivido num clima de grande incerteza devido à pandemia COVID. Os médicos de família (MF) foram sujeitos a inúmeras e exigentes solicitações, mostrando mais uma vez a sua centralidade no sistema de saúde português, embora sem nunca serem alvo de um justo reconhecimento e merecida valorização.
Foi neste contexto particularmente difícil que, no início do ano, tomaram posse os novos órgãos sociais da Associação Portuguesa de Medicina Geral e Familiar (APMGF). Com uma nova Direção Nacional, iniciou-se a concretização de um projeto que nasceu da necessidade sentida de mudança, reinvenção e readaptação.
Downloads
References
Monteiro P. Estudo Safira: reflexões sobre a prevalência e os padrões
de tratamento de fibrilhação auricular e risco cardiovascular em 7500
indivíduos com 65 ou mais anos [The SAFIRA study: A reflection on the
prevalence and treatment patterns of atrial fibrillation and cardiovascular
risk factors in 7500 elderly subjects]. Rev Port Cardiol. 2018;37(4):
-13. Portuguese
Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al.
Large-scale assessment of a smartwatch to identify atrial fibrillation.
N Engl J Med. 2019;381(20):1909-17.
Campion EW, Jarcho JA. Watched by Apple. N Engl J Med. 2019;381(20):
-5.
Qiu J, Wang Y. A smartwatch to identify atrial fibrillation. N Engl J Med.
;382(10):974-5.
U.S. Food & Drug Administration. Electrocardiograph software for overthe-
counter use [homepage]. FDA; 2018 [updated 2021 Sep 20]. Available
from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/
denovo.cfm?id=DEN180044
Strik M, Caillol T, Ramirez FD, Abu-Alrub S, Marchand H, Welte N, et al.
Validating QT-interval measurement using the Apple watch ECG to enable
remote monitoring during the COVID-19 pandemic. Circulation.
;142(4):416-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Portuguesa de Medicina Geral e Familiar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
